## UnitedHealth Group (UNH) — what it is (and how to read it through filings) UnitedHealth Group is a diversified U.S. healthcare company that reports results primarily through **UnitedHealthcare (insurance/benefits)** and **Optum (health services, pharmacy benefit management, data/analytics/tech)**, with Optum further broken out into **Optum Health, Optum Insight, and Optum Rx** as reportable segments. ["reportable segment financial information"](0000731766-25-000063|0) The most useful “map” of the business in filings is the **segment footnote/table** (10‑K), because it shows (i) revenue, (ii) earnings from operations, and (iii) key intercompany eliminations across the group. ["The following table presents"](0000731766-25-000063|0) --- ## Filing types you’ll use for UNH (and what each is “best for”) | Disclosure | What it’s best for | What to look up for UNH | |---|---|---| | **10‑K (annual report)** | Full business description, audited financials, segment note, and major risks/events | Segment profitability, medical cost dynamics, major one‑offs (e.g., divestitures), risk factor disclosures. ["10-K"](0000731766-25-000063|0) | | **10‑Q (quarterly report)** | Updates to the year: quarterly performance, interim financials and disclosures | In‑year MCR/operating cost ratio movement, working capital and cash flow shifts. ["10-Q"](0000731766-25-000305|1) | | **8‑K (current report)** | “Event-driven” disclosures (earnings releases, guidance changes, major incidents, governance) | Guidance reaffirmations/changes and other material events. ["Item 7.01"](0000731766-26-000020|0) | | **DEF 14A (proxy)** | Governance + executive pay + shareholder votes | Pay structure, say‑on‑pay support, governance policies. ["Executive Compensation"](0001104659-25-036829|0) | --- ## Financial snapshot (FY2024 vs FY2023 vs FY2022) — consolidated (USD, $ millions) *(These are GAAP figures from UNH’s consolidated statements of operations.)* ["(in millions)"](0000731766-25-000063|0) | Metric | FY2024 | FY2023 | FY2022 | |---|---:|---:|---:| | Total revenues | 400,278 ["Total revenues"](0000731766-25-000063|0) | 371,622 ["Total revenues"](0000731766-25-000063|0) | 324,162 ["Total revenues"](0000731766-25-000063|0) | | Earnings from operations | 32,287 ["Earnings from operations"](0000731766-25-000063|0) | 32,358 ["Earnings from operations"](0000731766-25-000063|0) | 28,435 ["Earnings from operations"](0000731766-25-000063|0) | | Loss on sale of subsidiary / held for sale | (8,310) ["Loss on sale"](0000731766-25-000063|0) | — ["Loss on sale"](0000731766-25-000063|0) | — ["Loss on sale"](0000731766-25-000063|0) | | Net earnings attributable to UNH common | 14,405 ["Net earnings attributable"](0000731766-25-000063|0) | 22,381 ["Net earnings attributable"](0000731766-25-000063|0) | 20,120 ["Net earnings attributable"](0000731766-25-000063|0) | | Diluted EPS (attrib. to UNH common) | $15.51 ["Diluted"](0000731766-25-000063|0) | $23.86 ["Diluted"](0000731766-25-000063|0) | $21.18 ["Diluted"](0000731766-25-000063|0) | | Medical care ratio (MCR) | 85.5% ["Medical care ratio"](0000731766-25-000063|0) | 83.2% ["Medical care ratio"](0000731766-25-000063|0) | 82.0% ["Medical care ratio"](0000731766-25-000063|0) | **Interpretation:** FY2024 revenue grew, but GAAP net income and EPS dropped sharply largely because UNH recorded a large **loss on sale/held‑for‑sale** that sits below operating income and reduced earnings before tax. ["Loss on sale of subsidiary"](0000731766-25-000063|0) --- ## Segment economics — where revenue and operating profit are generated (USD, $ millions) ### (A) Segment revenues and earnings from operations (FY2024 vs FY2023 vs FY2022) | Segment | Revenue FY2024 | Revenue FY2023 | Earnings from ops FY2024 | Earnings from ops FY2023 | |---|---:|---:|---:|---:| | UnitedHealthcare | 298,208 ["UnitedHealthcare"](0000731766-25-000063|0) | 281,360 ["UnitedHealthcare"](0000731766-25-000063|0) | 15,584 ["Earnings from operations"](0000731766-25-000063|0) | 16,415 ["Earnings from operations"](0000731766-25-000063|0) | | Optum Health | 105,358 ["Optum Health"](0000731766-25-000063|0) | 95,319 ["Optum Health"](0000731766-25-000063|0) | 7,770 ["Optum Health"](0000731766-25-000063|0) | 6,560 ["Optum Health"](0000731766-25-000063|0) | | Optum Insight | 18,757 ["Optum Insight"](0000731766-25-000063|0) | 18,932 ["Optum Insight"](0000731766-25-000063|0) | 3,097 ["Optum Insight"](0000731766-25-000063|0) | 4,268 ["Optum Insight"](0000731766-25-000063|0) | | Optum Rx | 133,231 ["Optum Rx"](0000731766-25-000063|0) | 116,087 ["Optum Rx"](0000731766-25-000063|0) | 5,836 ["Optum Rx"](0000731766-25-000063|0) | 5,115 ["Optum Rx"](0000731766-25-000063|0) | ### (B) How to read the eliminations (important for UNH) UNH’s segment table explicitly separates **unaffiliated revenue** from **affiliated revenue** (intercompany), and then shows **Optum eliminations** and **Corporate and eliminations** so consolidated revenue isn’t double-counted. For example, in FY2024 Optum shows **$150.887B** of “Total revenues – affiliated customers,” offset by **$(150.887B)** in “Corporate and eliminations.” ["Total revenues - affiliated customers"](0000731766-25-000063|0) ["Corporate and Eliminations"](0000731766-25-000063|0) **Interpretation:** Operationally, Optum sells a meaningful amount of services to UnitedHealthcare; economically it still matters (it’s real activity), but accounting removes it from consolidated revenue to avoid double counting. ["Total revenues - affiliated customers"](0000731766-25-000063|0) --- ## Balance sheet snapshot (FY-end 2024 vs 2023) — (USD, $ millions) | Line item | Dec 31, 2024 | Dec 31, 2023 | |---|---:|---:| | Cash & cash equivalents | 25,312 ["Cash and cash equivalents"](0000731766-25-000063|0) | 25,427 ["Cash and cash equivalents"](0000731766-25-000063|0) | | Total assets | 298,278 ["Total assets"](0000731766-25-000063|0) | 273,720 ["Total assets"](0000731766-25-000063|0) | | Medical costs payable | 34,224 ["Medical costs payable"](0000731766-25-000063|0) | 32,395 ["Medical costs payable"](0000731766-25-000063|0) | | Long-term debt (less current maturities) | 72,359 ["Long-term debt"](0000731766-25-000063|0) | 58,263 ["Long-term debt"](0000731766-25-000063|0) | | Total equity | 98,268 ["Total equity"](0000731766-25-000063|0) | 94,421 ["Total equity"](0000731766-25-000063|0) | --- ## “Events & special items” — what changed the story (from filings) ### 1) Change Healthcare cyberattack (disclosed in 10‑K; both operational and financial impacts) UNH disclosed it identified a cyberattack on Change Healthcare systems on **Feb. 21, 2024** and isolated impacted systems. ["on February 21, 2024"](0000731766-25-000063|0) They disclosed (FY2024): **>$9B** of interest-free loans to care providers, **$2.2B** of direct response costs, and **$867M** of estimated Optum Insight business disruption impacts. ["interest-free loans of more than $9 billion"](0000731766-25-000063|0) ["incurred $2.2 billion"](0000731766-25-000063|0) ["business disruption impacts of $867 million"](0000731766-25-000063|0) They also disclosed an estimated **~190 million** individuals impacted (to be confirmed/finalized with regulators). ["approximately 190 million"](0000731766-25-000063|0) **Why this matters analytically:** It’s simultaneously (i) a near-term cost headwind and disruption (especially Optum Insight), and (ii) a persistent regulatory/litigation/reputation risk tail. ["future risks and uncertainties"](0000731766-25-000063|0) ### 2) Brazil operations sale (portfolio reshaping; large accounting impact) UNH disclosed it completed the sale of its Brazil operations on **Feb. 6, 2024**, recording a **$7.1B** loss (including **$4.1B** related to cumulative FX translation losses previously in AOCI). ["completed the sale of its Brazil operations"](0000731766-25-000063|0) ["recorded a loss of $7.1 billion"](0000731766-25-000063|0) --- ## Key “risk” disclosure example (10‑K) UNH’s risk disclosures emphasize its exposure to cybersecurity threats and that it has been and expects to continue to be the target of cyberattacks; it specifically references the Change Healthcare cyberattack and associated sensitive data risks. ["regularly the target of attempted cyberattacks"](0000731766-25-000063|0) ["Change Healthcare business"](0000731766-25-000063|0) --- ## Governance & compensation disclosures (Proxy, DEF 14A) The proxy frames the key voting items (including **Say-on-Pay**) and describes executive compensation as a mix of salary, annual incentives, equity awards, and benefits. ["mix of base salary"](0001104659-25-036829|0) It also reports very high support for the Say‑on‑Pay vote at the prior annual meeting (example: **96%** support). ["96% of the votes cast"](0001104659-25-036829|0) --- ## Recent “event filing” example (8‑K) On **Jan. 12, 2026**, UNH filed an 8‑K (Item 7.01, Reg FD) stating management planned to meet with investors and intended to **reaffirm adjusted 2025 EPS expectations** previously disclosed on Oct. 28, 2025 (while noting year-end close was not complete and results could change). ["reaffirm our adjusted 2025 earnings per share expectations"](0000731766-26-000020|0) ["financial closing procedures"](0000731766-26-000020|0) --- If you want, I can add a second table that bridges **“why operating income was flat but net income fell”** (i.e., isolating the Brazil sale loss and interest/tax movements) using the same 10‑K lines.

## UnitedHealth Group (UNH) — what it is (and how to read it through filings) UnitedHealth Group is a diversified U.S. healthcare company that reports results primarily through **UnitedHealthcare (insurance/benefits)** and **Optum (health services, pharmacy benefit management, data/analytics/tech)**, with Optum further broken out into **Optum Health, Optum Insight, and Optum Rx** as reportable segments. ["reportable segment financial information"](0000731766-25-000063|0) The most useful “map” of the business in filings is the **segment footnote/table** (10‑K), because it shows (i) revenue, (ii) earnings from operations, and (iii) key intercompany eliminations across the group. ["The following table presents"](0000731766-25-000063|0) --- ## Filing types you’ll use for UNH (and what each is “best for”) | Disclosure | What it’s best for | What to look up for UNH | |---|---|---| | **10‑K (annual report)** | Full business description, audited financials, segment note, and major risks/events | Segment profitability, medical cost dynamics, major one‑offs (e.g., divestitures), risk factor disclosures. ["10-K"](0000731766-25-000063|0) | | **10‑Q (quarterly report)** | Updates to the year: quarterly performance, interim financials and disclosures | In‑year MCR/operating cost ratio movement, working capital and cash flow shifts. ["10-Q"](0000731766-25-000305|1) | | **8‑K (current report)** | “Event-driven” disclosures (earnings releases, guidance changes, major incidents, governance) | Guidance reaffirmations/changes and other material events. ["Item 7.01"](0000731766-26-000020|0) | | **DEF 14A (proxy)** | Governance + executive pay + shareholder votes | Pay structure, say‑on‑pay support, governance policies. ["Executive Compensation"](0001104659-25-036829|0) | --- ## Financial snapshot (FY2024 vs FY2023 vs FY2022) — consolidated (USD, $ millions) *(These are GAAP figures from UNH’s consolidated statements of operations.)* ["(in millions)"](0000731766-25-000063|0) | Metric | FY2024 | FY2023 | FY2022 | |---|---:|---:|---:| | Total revenues | 400,278 ["Total revenues"](0000731766-25-000063|0) | 371,622 ["Total revenues"](0000731766-25-000063|0) | 324,162 ["Total revenues"](0000731766-25-000063|0) | | Earnings from operations | 32,287 ["Earnings from operations"](0000731766-25-000063|0) | 32,358 ["Earnings from operations"](0000731766-25-000063|0) | 28,435 ["Earnings from operations"](0000731766-25-000063|0) | | Loss on sale of subsidiary / held for sale | (8,310) ["Loss on sale"](0000731766-25-000063|0) | — ["Loss on sale"](0000731766-25-000063|0) | — ["Loss on sale"](0000731766-25-000063|0) | | Net earnings attributable to UNH common | 14,405 ["Net earnings attributable"](0000731766-25-000063|0) | 22,381 ["Net earnings attributable"](0000731766-25-000063|0) | 20,120 ["Net earnings attributable"](0000731766-25-000063|0) | | Diluted EPS (attrib. to UNH common) | $15.51 ["Diluted"](0000731766-25-000063|0) | $23.86 ["Diluted"](0000731766-25-000063|0) | $21.18 ["Diluted"](0000731766-25-000063|0) | | Medical care ratio (MCR) | 85.5% ["Medical care ratio"](0000731766-25-000063|0) | 83.2% ["Medical care ratio"](0000731766-25-000063|0) | 82.0% ["Medical care ratio"](0000731766-25-000063|0) | **Interpretation:** FY2024 revenue grew, but GAAP net income and EPS dropped sharply largely because UNH recorded a large **loss on sale/held‑for‑sale** that sits below operating income and reduced earnings before tax. ["Loss on sale of subsidiary"](0000731766-25-000063|0) --- ## Segment economics — where revenue and operating profit are generated (USD, $ millions) ### (A) Segment revenues and earnings from operations (FY2024 vs FY2023 vs FY2022) | Segment | Revenue FY2024 | Revenue FY2023 | Earnings from ops FY2024 | Earnings from ops FY2023 | |---|---:|---:|---:|---:| | UnitedHealthcare | 298,208 ["UnitedHealthcare"](0000731766-25-000063|0) | 281,360 ["UnitedHealthcare"](0000731766-25-000063|0) | 15,584 ["Earnings from operations"](0000731766-25-000063|0) | 16,415 ["Earnings from operations"](0000731766-25-000063|0) | | Optum Health | 105,358 ["Optum Health"](0000731766-25-000063|0) | 95,319 ["Optum Health"](0000731766-25-000063|0) | 7,770 ["Optum Health"](0000731766-25-000063|0) | 6,560 ["Optum Health"](0000731766-25-000063|0) | | Optum Insight | 18,757 ["Optum Insight"](0000731766-25-000063|0) | 18,932 ["Optum Insight"](0000731766-25-000063|0) | 3,097 ["Optum Insight"](0000731766-25-000063|0) | 4,268 ["Optum Insight"](0000731766-25-000063|0) | | Optum Rx | 133,231 ["Optum Rx"](0000731766-25-000063|0) | 116,087 ["Optum Rx"](0000731766-25-000063|0) | 5,836 ["Optum Rx"](0000731766-25-000063|0) | 5,115 ["Optum Rx"](0000731766-25-000063|0) | ### (B) How to read the eliminations (important for UNH) UNH’s segment table explicitly separates **unaffiliated revenue** from **affiliated revenue** (intercompany), and then shows **Optum eliminations** and **Corporate and eliminations** so consolidated revenue isn’t double-counted. For example, in FY2024 Optum shows **$150.887B** of “Total revenues – affiliated customers,” offset by **$(150.887B)** in “Corporate and eliminations.” ["Total revenues - affiliated customers"](0000731766-25-000063|0) ["Corporate and Eliminations"](0000731766-25-000063|0) **Interpretation:** Operationally, Optum sells a meaningful amount of services to UnitedHealthcare; economically it still matters (it’s real activity), but accounting removes it from consolidated revenue to avoid double counting. ["Total revenues - affiliated customers"](0000731766-25-000063|0) --- ## Balance sheet snapshot (FY-end 2024 vs 2023) — (USD, $ millions) | Line item | Dec 31, 2024 | Dec 31, 2023 | |---|---:|---:| | Cash & cash equivalents | 25,312 ["Cash and cash equivalents"](0000731766-25-000063|0) | 25,427 ["Cash and cash equivalents"](0000731766-25-000063|0) | | Total assets | 298,278 ["Total assets"](0000731766-25-000063|0) | 273,720 ["Total assets"](0000731766-25-000063|0) | | Medical costs payable | 34,224 ["Medical costs payable"](0000731766-25-000063|0) | 32,395 ["Medical costs payable"](0000731766-25-000063|0) | | Long-term debt (less current maturities) | 72,359 ["Long-term debt"](0000731766-25-000063|0) | 58,263 ["Long-term debt"](0000731766-25-000063|0) | | Total equity | 98,268 ["Total equity"](0000731766-25-000063|0) | 94,421 ["Total equity"](0000731766-25-000063|0) | --- ## “Events & special items” — what changed the story (from filings) ### 1) Change Healthcare cyberattack (disclosed in 10‑K; both operational and financial impacts) UNH disclosed it identified a cyberattack on Change Healthcare systems on **Feb. 21, 2024** and isolated impacted systems. ["on February 21, 2024"](0000731766-25-000063|0) They disclosed (FY2024): **>$9B** of interest-free loans to care providers, **$2.2B** of direct response costs, and **$867M** of estimated Optum Insight business disruption impacts. ["interest-free loans of more than $9 billion"](0000731766-25-000063|0) ["incurred $2.2 billion"](0000731766-25-000063|0) ["business disruption impacts of $867 million"](0000731766-25-000063|0) They also disclosed an estimated **~190 million** individuals impacted (to be confirmed/finalized with regulators). ["approximately 190 million"](0000731766-25-000063|0) **Why this matters analytically:** It’s simultaneously (i) a near-term cost headwind and disruption (especially Optum Insight), and (ii) a persistent regulatory/litigation/reputation risk tail. ["future risks and uncertainties"](0000731766-25-000063|0) ### 2) Brazil operations sale (portfolio reshaping; large accounting impact) UNH disclosed it completed the sale of its Brazil operations on **Feb. 6, 2024**, recording a **$7.1B** loss (including **$4.1B** related to cumulative FX translation losses previously in AOCI). ["completed the sale of its Brazil operations"](0000731766-25-000063|0) ["recorded a loss of $7.1 billion"](0000731766-25-000063|0) --- ## Key “risk” disclosure example (10‑K) UNH’s risk disclosures emphasize its exposure to cybersecurity threats and that it has been and expects to continue to be the target of cyberattacks; it specifically references the Change Healthcare cyberattack and associated sensitive data risks. ["regularly the target of attempted cyberattacks"](0000731766-25-000063|0) ["Change Healthcare business"](0000731766-25-000063|0) --- ## Governance & compensation disclosures (Proxy, DEF 14A) The proxy frames the key voting items (including **Say-on-Pay**) and describes executive compensation as a mix of salary, annual incentives, equity awards, and benefits. ["mix of base salary"](0001104659-25-036829|0) It also reports very high support for the Say‑on‑Pay vote at the prior annual meeting (example: **96%** support). ["96% of the votes cast"](0001104659-25-036829|0) --- ## Recent “event filing” example (8‑K) On **Jan. 12, 2026**, UNH filed an 8‑K (Item 7.01, Reg FD) stating management planned to meet with investors and intended to **reaffirm adjusted 2025 EPS expectations** previously disclosed on Oct. 28, 2025 (while noting year-end close was not complete and results could change). ["reaffirm our adjusted 2025 earnings per share expectations"](0000731766-26-000020|0) ["financial closing procedures"](0000731766-26-000020|0) --- If you want, I can add a second table that bridges **“why operating income was flat but net income fell”** (i.e., isolating the Brazil sale loss and interest/tax movements) using the same 10‑K lines.